Sign Up to like & get
recommendations!
0
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1380
Abstract: REFERENCES Background: Omadacycline, a novel aminomethylcycline antibiotic active against Gram-positive and Gram–negative organisms, is in development for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).…
read more here.
Keywords:
plasma;
tigecycline;
elf penetration;
omadacycline tigecycline ... See more keywords